GeoVax Labs Inc. [NASDAQ: GOVX] surged by $2.06 during the normal trading session on Monday and reaching a high of $7.40 during the day while it closed the day at $5.36. The company report on January 11, 2021 that GeoVax Awarded NIH Grant to Advance COVID-19 Vaccine Development.
Company Focused on Single-dose Vaccine Against Multiple COVID Strains.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
via NewMediaWire — GeoVax Labs, Inc. (NasdaqCM: GOVX), a biotechnology company developing immunotherapies and vaccines against cancers and infectious diseases, announced that the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), has awarded the Company a Small Business Innovative Research (SBIR) grant in support of its development of a vaccine against SARS-CoV-2, the virus that causes COVID-19.
GeoVax Labs Inc. stock has also gained 61.45% of its value over the past 7 days. However, GOVX stock has inclined by 66.46% in the 3 months of the year. Over the past six months meanwhile, it has lost -40.43% and gained 58.58% year-on date.
The market cap for GOVX stock reached $21.28 million, with 3.81 million shares outstanding and 2.82 million shares in the current float. Compared to the average trading volume of 1.48M shares, GOVX reached a trading volume of 50550510 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about GeoVax Labs Inc. [GOVX]:
Maxim Group have made an estimate for GeoVax Labs Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on November 19, 2020.
The Average True Range (ATR) for GeoVax Labs Inc. is set at 0.76, with the Price to Sales ratio for GOVX stock in the period of the last 12 months amounting to 11.82. The Price to Book ratio for the last quarter was 0.39, with the Price to Cash per share for the same quarter was set at 2.92.
GOVX stock trade performance evaluation
GeoVax Labs Inc. [GOVX] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 61.45. With this latest performance, GOVX shares dropped by -6.46% in over the last four-week period, additionally sinking by -40.43% over the last 6 months – not to mention a drop of -73.20% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GOVX stock in for the last two-week period is set at 71.57, with the RSI for the last a single of trading hit 78.97, and the three-weeks RSI is set at 65.67 for GeoVax Labs Inc. [GOVX]. The present Moving Average for the last 50 days of trading for this stock 3.17, while it was recorded at 3.76 for the last single week of trading, and 6.75 for the last 200 days.
GeoVax Labs Inc. [GOVX]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and GeoVax Labs Inc. [GOVX] shares currently have an operating margin of -201.76. GeoVax Labs Inc.’s Net Margin is presently recorded at -201.60.
Reflecting on the efficiency of the workforce at the company, GeoVax Labs Inc. [GOVX] managed to generate an average of -$395,105 per employee. Receivables Turnover for the company is 12.35 with a Total Asset Turnover recorded at a value of 2.12.GeoVax Labs Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 12.70 and a Current Ratio set at 12.70.
GeoVax Labs Inc. [GOVX]: Insider Ownership positions
There are presently around $1 million, or 22.50% of GOVX stock, in the hands of institutional investors. The top three institutional holders of GOVX stocks are: SABBY MANAGEMENT, LLC with ownership of 240,654, which is approximately New of the company’s market cap and around 6.40% of the total institutional ownership; HUDSON BAY CAPITAL MANAGEMENT LP, holding 80,000 shares of the stock with an approximate value of $0.26 million in GOVX stocks shares; and ARMISTICE CAPITAL, LLC, currently with $0.17 million in GOVX stock with ownership of nearly New of the company’s market capitalization.
Positions in GeoVax Labs Inc. stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 4 institutional holders increased their position in GeoVax Labs Inc. [NASDAQ:GOVX] by around 371,968 shares. Additionally, 0 investors decreased positions by around 0 shares, while 0 investors held positions by with 0 shares. The mentioned changes placed institutional holdings at 371,968 shares, according to the latest SEC report filing. GOVX stock had 4 new institutional investments in for a total of 371,968 shares, while 0 institutional investors sold positions of 0 shares during the same period.